Halozyme Therapeutics Inc. Common Stock vs Qnity Electronics Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B), while Qnity Electronics Inc. Common Stock trades at $125.75 (market cap $26.50B). The key difference: Qnity Electronics Inc. Common Stock is far larger — about 2.1× Halozyme Therapeutics Inc. Common Stock's market cap, and Qnity Electronics Inc. Common Stock pays a 0.25% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Qnity Electronics Inc. Common Stock for 0 Days on average.
| HALO | Q | |
|---|---|---|
Market Cap | $12.58B | $26.50B |
Volume | 2,179,278 | 1,501,084 |
Sector | Health | Technology |
52-Week High | $115.22 | $175.64 |
52-Week Low | $61.63 | $73.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.49B | $29.56B |
Dividend Yield | — | 0.25% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Qnity Electronics provides materials and solutions for semiconductor manufacturing and electronic systems. Its portfolio supports chip fabrication, advanced packaging, interconnects, and thermal management.
Read more on Q →